Latest KFF Health News Stories
Use Of HIV-Prevention Drug Grows, But Lags Among Non-Whites
The pill, known as PrEP, can reduce the risk of contracting the virus that causes AIDS by 90 percent. Its use has expanded sharply in recent years — but primarily among a white demographic.
Todo lo que debes saber sobre la nueva tarjeta de Medicare… ¡para evitar fraudes!
A partir de abril, el programa de salud federal para adultos mayores comenzará a enviar nuevas tarjetas que ya no contendrán el número de seguro social del beneficiario.
Impuesto a los millonarios genera grandes beneficios para pacientes de salud mental
Un impuesto estatal a los ricos ha impulsado significativamente los programas de salud mental en el condado más grande de California, ayudando a reducir la falta de vivienda, el encarcelamiento y la hospitalización.
Editorial pages highlight these health topics and others.
Media outlets report on news from Georgia, Minnesota, Kansas, California, Louisiana, Wisconsin, Missouri, Florida and Texas.
Virginia Governor Calls Lawmakers Back For Special Session To Work Out Medicaid Expansion
The state Legislature concluded its regular session without a budget, mainly due to disagreement on whether to expand Medicaid. The House is in favor of it, while the Senate hasn’t budged from its stance against expansion.
‘It’s Every Clinic’s Nightmare’: Recent Malfunctions At Fertility Centers Shake Industry, Consumers
The New York Times offers a guide on what to look for while deciding what clinic to use to freeze eggs. Meanwhile, people who stored their eggs and embryos at the facilities grieve over the loss of their “future families.”
More Than 400K Deaths A Year Can Be Attributed To Lead Poisoning
A new study highlights the dangers of lead beyond its effect on IQ. In other public health news: cancer, nausea and students with disabilities.
Hospitals Remain Quiet On Gun Control Debate In Contrast To Others In Medical Community
While many in the health industry are speaking out in favor of gun control, major hospital groups have avoided taking a firm stance in the debate, instead focusing on public health awareness in general.
When he was first diagnosed with the disease, Stephen Hawking was given two years to live. He went on to become one of the world’s most well-known scientists.
Large Majority Of Shareholders Support Plan For CVS To Purchase Aetna
Federal regulators still have to approve the deal between the nation’s largest pharmacy and the third-largest health insurer.
Why Aren’t Americans Getting Good Bang For Their Buck On Health Care? Blame High Salaries And Prices
A new study looks at why Americans are spending twice as much as other high-income countries on health care. And debunked some common myths along the way.
The White House advisory group suggested that pricing frameworks are needed for deciding the value of cancer medicines, a step that is already taken in many other countries.
Lawmakers May Scale Back Medicare Drug Changes In Spending Bill In A Win For Pharma Lobbyists
The original provision shifted a chunk of Medicare drug costs onto drugmakers and away from insurers’ responsibility.
House Fails To Pass Right-To-Try Bill In Surprising Defeat To Trump, Conservatives’ Agenda
The legislation, which critics said gave patients false hope, needed a two-thirds majority to pass. The House can still work on the Senate’s version, which would only require a simple majority vote, if lawmakers want to move forward with a bill.
Following Weeks Of Infighting And Scandal At VA, Trump Mulls Ousting Embattled Secretary
Veterans Affairs Secretary David Shulkin, following a travel scandal, spoke about rousting political foes in the agency who he said were trying to undermine him. As President Donald Trump takes other steps to re-align his cabinet, Shulkin may be the next to go.
After Trying Nearly Everything Else To Protect Drug Profits, Pharma Tries Actually Cutting Prices
News outlets report on stories related to pharmaceutical pricing.
Read recent commentaries about drug-cost issues.
Today’s early morning highlights from the major news organizations.
Opioid Maker Funds Efforts To Fight Addiction: Is It ‘Blood Money’ Or Charity?
Purdue Pharma, whose signature product helped fuel the opioid epidemic, now wants to help treat it — or at least salvage its own reputation.